Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 6056-6057 [2016-02121]


[Federal Register Volume 81, Number 23 (Thursday, February 4, 2016)]
[Pages 6056-6057]
From the Federal Register Online via the Government Publishing Office []
[FR Doc No: 2016-02121]



Advisory Committee on the Medical Uses of Isotopes: Meeting 

AGENCY: U.S. Nuclear Regulatory Commission

ACTION: Notice of Meeting.


SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
March 17-18, 2016. A sample of agenda items to be discussed during the 
public session includes: A discussion on the reporting of medical 
events for various modalities; an update on medical-related events; a 
discussion on the training and experience requirements for authorized 
users of alpha and beta emitters; an update on the licensing guidance 
for yttrium-90 microsphere brachytherapy; and a discussion on the 
licensing guidance for the Leksell Gamma Knife[supreg] 
IconTM unit. The agenda is subject to change. The current 
agenda and any

[[Page 6057]]

updates will be available at or by emailing Ms. Sophie Holiday 
at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: March 17, 2016, from 9:30 a.m. to 
5:00 p.m. and March 18, 2016, from 8:00 a.m. to 11:30 a.m.
    Data and Time for Closed Sessions: March 17, 2016, from 7:30 a.m. 
to 9:30 a.m., March 18, 2016, from 7:30 a.m. to 8:00 a.m., and March 
18, 2016, from 12:00 p.m. to 1:00 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
    Contact Information: Ms. Sophie J. Holiday, email:, telephone: (301) 415-7865.

Conduct of the Meeting

    Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by March 15, 2016, and must pertain to 
the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site on or about April 29, 2016.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 Code of Federal Regulations Part 7.

    Dated at Rockville, Maryland, this 28th day of January 2016.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2016-02121 Filed 2-3-16; 8:45 am]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.